Can Fite (Israel) Today
| CANF Stock | 2.60 0.10 3.70% |
Performance1 of 100
| Odds Of DistressOver 67
|
Can Fite is trading at 2.60 as of the 6th of May 2024, a -3.7 percent decrease since the beginning of the trading day. The stock's open price was 2.7. Can Fite has more than 67 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Can Fite Biopharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of April 2024 and ending today, the 6th of May 2024. Click here to learn more.
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel. The company has 1.01 B outstanding shares. More on Can Fite Biopharma
Moving together with Can Stock
| 0.66 | DIFI | Direct Finance TA | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Can Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Can Fite's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Can Fite or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Pnina Fishman |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Can Fite Biopharma (CANF) is traded on Tel Aviv Stock Exchange in Israel and employs 8 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 41.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Can Fite's market, we take the total number of its shares issued and multiply it by Can Fite's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Can Fite Biopharma operates under Biotechnology sector and is part of Health Care industry. The entity has 1.01 B outstanding shares.
Can Fite Biopharma has accumulated about 3.21 M in cash with (9.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Check Can Fite Probability Of Bankruptcy
Can Stock Price Odds Analysis
What are Can Fite's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Can Fite jumping above the current price in 90 days from now is about 78.81%. The Can Fite Biopharma probability density function shows the probability of Can Fite stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Can Fite has a beta of 0.2672 suggesting as returns on the market go up, Can Fite average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Can Fite Biopharma will be expected to be much smaller as well. Additionally, can Fite Biopharma has an alpha of 0.0063, implying that it can generate a 0.006293 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Can Fite to move above the current price in 90 days from now is about 78.81 (This Can Fite Biopharma probability density function shows the probability of Can Stock to fall within a particular range of prices over 90 days) .
Can Fite Biopharma Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Can Fite market risk premium is the additional return an investor will receive from holding Can Fite long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Can Fite. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Can Fite's alpha and beta are two of the key measurements used to evaluate Can Fite's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.81 | |||
| Semi Deviation | 2.17 | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.06 |
Can Stock Against Markets
Picking the right benchmark for Can Fite stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Can Fite stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Can Fite is critical whether you are bullish or bearish towards Can Fite Biopharma at a given time. Please also check how Can Fite's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Can Fite without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Can Fite Corporate Management
Elected by the shareholders, the Can Fite's board of directors comprises two types of representatives: Can Fite inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Can. The board's role is to monitor Can Fite's management team and ensure that shareholders' interests are well served. Can Fite's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Can Fite's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Motti Farbstein | Chief Officer | Profile | |
| Sari Fishman | VP Devel | Profile | |
| Ilan Cohn | CoFounder Chairman | Profile | |
| FACP FACR | Clinical Advisor | Profile |
How to buy Can Stock?
Before investing in Can Fite, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Can Fite. To buy Can Fite stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Can Fite. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Can Fite stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Can Fite Biopharma stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Can Fite Biopharma stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Can Fite Biopharma, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Can Stock please use our How to Invest in Can Fite guide.
Already Invested in Can Fite Biopharma?
The danger of trading Can Fite Biopharma is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Can Fite is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Can Fite. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Can Fite Biopharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Can Fite Biopharma is a strong investment it is important to analyze Can Fite's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Can Fite's future performance. For an informed investment choice regarding Can Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Can Fite Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Can Stock analysis
When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |